Federal Upper Limit List Should Include All Eligible Drug Products, OIG Says
Executive Summary
The HHS Office of the Inspector General is recommending that the Federal Upper Limit list include all eligible prescription drugs in order to reduce costs in the Medicaid program
You may also be interested in...
OIG To Study AWP Prices For Physician-Administered Drugs
The HHS Office of the Inspector General will conduct studies of AWP with the aim of allowing state Medicaid programs to reimburse physician-administered drugs at a lower price
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials